Disease Info Card

Central Nervous System Lymphoma

Information about Central Nervous System Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Central Nervous System Lymphoma

Most recent studies have shown that Central Nervous System Lymphoma shares some biological mechanisms with acquired-immunodeficiency-syndrome, b-cell-lymphomas, brain-neoplasms, central-nervous-system-neoplasms, cns-disorder, diffuse-large-b-cell-lymphoma, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, leukoencephalopathies, lymphoma, lymphoma-aids-related, lymphoma-non-hodgkin, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, nervousness, neurotoxicity-syndromes, primary-central-nervous-system-lymphoma, toxoplasmosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Central Nervous System Lymphoma, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Proliferation, Coagulation, Cognition, Complement-dependent Cytotoxicity, Drug Resistance, Enucleation, Immune Response, Localization, Methylation, Myelination, Oncogenesis, Pathogenesis, Response To Radiation, Secretion, Transport, Tropism

Quite a number of genes have been found to play important roles in Central Nervous System Lymphoma, such as BCL2, BCL6, CD4, CDKN2A, CSF2, DDIT3, IL10, IL2, IL6, KRT20, LAMC2, MID1, MME, MS4A1, PGR, POMT1, SMUG1, TMEM37. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.